eye, with Scer\GAL4GMR.PF
Expression of foxoScer\UAS.cKb under the control of Scer\GAL4GMR.PF results in mild defects in the eye.
Expression of foxoScer\UAS.cKb under the control of Scer\GAL4elav.Switch.PO in the presence of RU486 throughout the lifespan has no effect on lifespan.
Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, enhanceable by LrrkUAS.cIa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, enhanceable by Hsap\LRRK2I2020T.UAS, Scer\GAL4GMR.PF
LrrkI1915T.UAS, Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, enhanceable by Diap1th-1/th[+]
Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, enhanceable by LrrkI1915T.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, enhanceable by LrrkR1069G.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, enhanceable by LrrkY1383C.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, enhanceable by Hsap\LRRK2UAS.cVa, Scer\GAL4GMR.PF
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has abnormal neuroanatomy | adult stage | RU486 conditional phenotype, suppressible by W[+]/hid1
Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, suppressible by AktUAS.Tag:HA, Scer\GAL4GMR.PF
LrrkI1915T.UAS, Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, suppressible | partially by DroncKG02994/Nc[+]
LrrkI1915T.UAS, Scer\GAL4GMR.PF, foxoUAS.cKb has visible phenotype, suppressible | partially by W[+]/hid1
LrrkUAS.cIa, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has abnormal neuroanatomy | adult stage | RU486 conditional phenotype
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has abnormal neuroanatomy | adult stage | RU486 conditional phenotype
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has abnormal locomotor behavior | adult stage | RU486 conditional phenotype
LrrkY1383C.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has short lived | RU486 conditional phenotype
LrrkY1383C.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has abnormal neuroanatomy | adult stage | RU486 conditional phenotype
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has short lived | RU486 conditional phenotype
Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, enhanceable by LrrkUAS.cIa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, enhanceable by Hsap\LRRK2I2020T.UAS, Scer\GAL4GMR.PF
LrrkI1915T.UAS, Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, enhanceable by Diap1th-1/th[+]
Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, enhanceable by LrrkI1915T.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, enhanceable by LrrkR1069G.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, enhanceable by LrrkY1383C.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, enhanceable by Hsap\LRRK2UAS.cVa, Scer\GAL4GMR.PF
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic neuron | RU486 conditional phenotype, suppressible by W[+]/hid1
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic PPL1 neuron | RU486 conditional phenotype, suppressible by W[+]/hid1
Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, suppressible by AktUAS.Tag:HA, Scer\GAL4GMR.PF
LrrkI1915T.UAS, Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, suppressible | partially by DroncKG02994/Nc[+]
LrrkI1915T.UAS, Scer\GAL4GMR.PF, foxoUAS.cKb has eye phenotype, suppressible | partially by W[+]/hid1
LrrkUAS.cIa, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic neuron | RU486 conditional phenotype
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic neuron | RU486 conditional phenotype
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic PPL1 neuron | RU486 conditional phenotype
LrrkI1915T.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic PPM3 neuron | RU486 conditional phenotype
LrrkUAS.cIa, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic PPL1 neuron | RU486 conditional phenotype
LrrkUAS.cIa, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic PPM3 neuron | RU486 conditional phenotype
LrrkY1383C.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic neuron | RU486 conditional phenotype
LrrkY1383C.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic PPL1 neuron | RU486 conditional phenotype
LrrkY1383C.UAS, Scer\GAL4elav.Switch.PO, foxoUAS.cKb has dopaminergic PPM3 neuron | RU486 conditional phenotype
The severity of the eye defects caused by expression of foxoScer\UAS.cKb under the control of Scer\GAL4GMR.PF are enhanced by co-expression of either LrrkScer\UAS.cIa, LrrkI1915T.Scer\UAS, LrrkR1069G.Scer\UAS or LrrkY1383C.Scer\UAS.
The severity of the eye defects caused by expression of foxoScer\UAS.cKb under the control of Scer\GAL4GMR.PF is suppressed by co-expression of Akt1Scer\UAS.T:Ivir\HA1.
Expression of foxoScer\UAS.cKb under the control of Scer\GAL4elav.Switch.PO in a Lrrke03680/Lrrke03680 background in the presence of RU486 throughout the lifespan has no effect on lifespan.
Co-expression of foxoScer\UAS.cKb and LrrkScer\UAS.cIa under the control of Scer\GAL4elav.Switch.PO in the presence of RU486 throughout the lifespan has no effect on lifespan. These flies show an age-dependent decrease in the number of PPM1/2, PPM3 and PPL1 neurons.
Co-expression of foxoScer\UAS.cKb and LrrkY1383C.Scer\UAS under the control of Scer\GAL4elav.Switch.PO in the presence of RU486 throughout the lifespan results in a reduction in lifespan. These flies show an age-dependent decrease in the number of PPM1/2, PPM3 and PPL1 neurons.
Co-expression of foxoScer\UAS.cKb and LrrkI1915T.Scer\UAS under the control of Scer\GAL4elav.Switch.PO in the presence of RU486 throughout the lifespan results in a reduction in lifespan. These flies show an age-dependent decrease in the number of PPM1/2, PPM3 and PPL1 neurons.
The eye phenotype caused by co-expression of foxoScer\UAS.cKb and LrrkI1915T.Scer\UAS under the control of Scer\GAL4GMR.PF is significantly suppressed if the flies also carry either NcKG02994/+ or W1/+.
The eye phenotype caused by co-expression of foxoScer\UAS.cKb and LrrkI1915T.Scer\UAS under the control of Scer\GAL4GMR.PF is enhanced by th1/+.
The degeneration of the PPM1/2 and PPL1 neurons which is seen in flies co-expressing foxoScer\UAS.cKb and LrrkI1915T.Scer\UAS under the control of Scer\GAL4elav.Switch.PO in the presence of RU486 is suppressed if they alo carry W1/+.
The severity of the eye defects caused by expression of foxoScer\UAS.cKb under the control of Scer\GAL4GMR.PF are enhanced by co-expression of either Hsap\LRRK2Scer\UAS.cVa or Hsap\LRRK2I2020T.Scer\UAS.